Glibenclamide.
D000818:Animals; D003510:Cyclohexanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy; D011485:Protein Binding; D051381:Rats; D013450:Sulfones / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013450:Sulfones; D014508:Urea